Needle-free immunizationsDecember 02, 2005Samir Mitragotri, a professor of chemical engineering at the University of California, Santa Barbara, says the myriad shortcomings of injections have led to active research and development of needle-free methods of immunization. While most people prefer to avoid injections, the stakes are enormously higher than just helping people avoid a disagreeable prick of a needle. In third world countries, improper and unsafe use of the needles used in injections causes millions of cases of hepatitis B and hepatitis C, and thousands of HIV infections. The World Health Organization has estimated that as many as one-third of immunization injections are unsafe in four of it six geographical regions. In a paper published today in Nature Reviews, "Immunization Without Needles," Mitragotri reviews in detail the characteristics - and pros and cons - of the currently available methods of immunization, which include topical application to the skin, pills, nasal sprays, injections, and others. Considerable advances have been made in the past decade, especially in transdermal (through the skin) and nasal immunization. "Unfortunately, because of the development costs of new immunization methods, use of needle-free immunization might initially push the direct cost of immunizations higher," says Mitragotri. "But the secondary costs of needle-based immunization - infection and disease - are high and could be prevented with needle-free methods." Mitragotri says that he anticipates that needle-free methods will reduce the economic burden associated with needle-caused infections, eventually proving to be economically feasible. A wide range of interdisciplinary researchers and businesses are focusing on needle-free immunization delivery methods, says Mitragotri, helping ensure that needle-free immunizations will eventually be commonly used. University of California-Santa Barbara |
|||||||||||||||||||||
| Related Immunization Current Events and Immunization News Articles PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Pandemic flu vaccine campaigns may be undermined by coincidental medical events The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines. Older Patients with Dementia at Increased Risk for Flu Mortality An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia. Flu shots not to be sneezed at Two in five at-risk American adults who would benefit from vaccination against seasonal flu are missing out on the protective shots because they believe they do not need them and are not inclined to be vaccinated. MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2009 National Conference & Exhibition that add to the company's growing body of research on the burden of respiratory syncytial virus (RSV) on children, as well as pediatric infectious disease prevention. Outfoxing pox: Developing a new class of vaccine candidates In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox. African cattle to be protected from killer disease Millions of African families could be saved from destitution thanks to a much-needed vaccine that is being mass-produced in a drive to protect cattle against a deadly parasite. Protect Children First With H1N1 Flu Vaccine, Says UAB-Based National Pediatric Disease Expert The optimal way to control swine flu, the new H1N1 virus that emerged as a global threat in 2009, is to vaccinate children with the planned H1N1 flu shot, says the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases. Pregnant women need flu shots Pregnant women should be sure to get all their flu shots as soon as the vaccines become available this year to protect them against both the seasonal flu and the H1N1 (swine) flu, according to eight leading national maternal and infant health organizations. More Immunization Current Events and Immunization News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||